Literature DB >> 30361417

Disappearance of a strong triple positivity for antiphospholipid antibodies after treatment with anakinra.

Erik Arnaud1, Camille Soulier2, Jean-Christophe Gris3,4,5,6.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30361417      PMCID： PMC6355488          DOI： 10.3324/haematol.2018.205484

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  9 in total

Review 1.  Regulatory T cells and B cells: implication on autoimmune diseases.

Authors:  Ping Wang; Song Guo Zheng
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

3.  Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab.

Authors:  Savino Sciascia; Elena Rubini; Massimo Radin; Irene Cecchi; Daniela Rossi; Dario Roccatello
Journal:  Ann Rheum Dis       Date:  2018-05-18       Impact factor: 19.103

4.  Regulatory immune responses induced by IL-1 receptor antagonist in rheumatoid arthritis.

Authors:  Xiaoyin Niu; Dongyi He; Shaohua Deng; Weiyi Li; Yebin Xi; Changyi Xie; Ting Jiang; Jingwu Z Zhang; Chen Dong; Guangjie Chen
Journal:  Mol Immunol       Date:  2011-09-22       Impact factor: 4.407

5.  Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

Authors:  Michelle Petri; Ana-Maria Orbai; Graciela S Alarcón; Caroline Gordon; Joan T Merrill; Paul R Fortin; Ian N Bruce; David Isenberg; Daniel J Wallace; Ola Nived; Gunnar Sturfelt; Rosalind Ramsey-Goldman; Sang-Cheol Bae; John G Hanly; Jorge Sánchez-Guerrero; Ann Clarke; Cynthia Aranow; Susan Manzi; Murray Urowitz; Dafna Gladman; Kenneth Kalunian; Melissa Costner; Victoria P Werth; Asad Zoma; Sasha Bernatsky; Guillermo Ruiz-Irastorza; Munther A Khamashta; Soren Jacobsen; Jill P Buyon; Peter Maddison; Mary Anne Dooley; Ronald F van Vollenhoven; Ellen Ginzler; Thomas Stoll; Christine Peschken; Joseph L Jorizzo; Jeffrey P Callen; S Sam Lim; Barri J Fessler; Murat Inanc; Diane L Kamen; Anisur Rahman; Kristjan Steinsson; Andrew G Franks; Lisa Sigler; Suhail Hameed; Hong Fang; Ngoc Pham; Robin Brey; Michael H Weisman; Gerald McGwin; Laurence S Magder
Journal:  Arthritis Rheum       Date:  2012-08

Review 6.  Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models.

Authors:  Yoichiro Iwakura
Journal:  Cytokine Growth Factor Rev       Date:  2002 Aug-Oct       Impact factor: 7.638

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile.

Authors:  V Pengo; A Ruffatti; T Del Ross; M Tonello; S Cuffaro; A Hoxha; A Banzato; E Bison; G Denas; A Bracco; S Padayattil Jose
Journal:  J Thromb Haemost       Date:  2013-08       Impact factor: 5.824

Review 9.  14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends.

Authors:  Doruk Erkan; Cassyanne L Aguiar; Danieli Andrade; Hannah Cohen; Maria J Cuadrado; Adriana Danowski; Roger A Levy; Thomas L Ortel; Anisur Rahman; Jane E Salmon; Maria G Tektonidou; Rohan Willis; Michael D Lockshin
Journal:  Autoimmun Rev       Date:  2014-01-24       Impact factor: 9.754
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.